pantoprazole and rabeprazole

pantoprazole has been researched along with rabeprazole in 108 studies

Research

Studies (108)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (2.78)	18.2507
2000's	53 (49.07)	29.6817
2010's	37 (34.26)	24.3611
2020's	15 (13.89)	2.80

Authors

Authors	Studies
Bariwal, J; Bhosale, AV; Jagtap, JR; Jain, KS; Kale, AP; Shah, AK; Shelke, SM	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ	1
Castillo, R; Hernández-Campos, A; Hernández-Luis, F; Pérez-Villanueva, J; Romo-Mancillas, A; Yépez-Mulia, L	1
Fako, VE; Liu, JY; Pflug, B; Wu, X; Zhang, JT	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Bala, V; Chhonker, YS	1
Beghyn, T; Bosc, D; Charton, J; Deprez, B; Deprez-Poulain, R; Guillaume, V; Herledan, A; Hermant, P; Landry, V; Leroux, F; Liang, W; Pottiez, V; Sheng, L; Tang, WJ; Urata, S; Warenghem, S	1
Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF	1
Hildebrandt, AG; Kleeberg, U; Krusekopf, S; Ruckpaul, K	1
Besancon, M; Sachs, G; Shin, JM; Simon, A	1
Andersson, K; Bayati, A; Lee, H; Lorentzon, P	1
Thomson, AB	1
Humphries, TJ	1
Bardou, M	1
Gerson, LB; Triadafilopoulos, G	1
Caro, JJ; Salas, M; Ward, A	1
Herszényi, L; Tulassay, Z	1
Kromer, W	1
Barth, J; Hahne, W	1
Calvet, X; Gisbert, JP; Vallve, M; Vergara, M	1
Tahboub, RM; Vanderhoff, BT	1
Frissora, C; Katz, PO	1
Kleeberg, U; Krusekopf, S; Roots, I	1
Blum, AL; Dorta, G; Jornod, P; Pantoflickova, D; Ravic, M	1
Hellström, PM; Vitols, S	1
Balashova, NN; Busarova, GA; Maev, IV	1
Gong, J; Luo, JY; Niu, CY; Wang, XQ; Zhu, YL	1
Chen, Y; Katz, PO; Miner, P; Sostek, M	1
Ahlström, M; Andersson, TB; Li, XQ; Weidolf, L	1
Lind, T; Röhss, K; Wilder-Smith, C	1
Alonso, C; Bernal, JL; del Nozal, MJ; Jiménez, JJ; Toribio, L	1
Hellström, PM	1
Iinuma, K; Kato, S; Konno, M; Maisawa, S; Nakayama, Y; Shimizu, T; Tajiri, H; Toyoda, S; Yoshimura, N	1
Katz, PO	1
Pauly, MV; Wang, YR	1
Barry, M; Bennett, K; McGowan, B; Tilson, L	1
Brown, RE; Remák, E; Robinson, A; Yuen, C	1
Calvet, X; Gomollón, F	1
Avorn, J; Canning, C; Dormuth, CR; Glynn, RJ; Maclure, M; Schneeweiss, S	1
Gunaratnam, NT; Inadomi, J; Jessup, TP; Lascewski, DP	1
Clark, DW; Strandell, J	1
Edwards, SJ; Lind, T; Lundell, L	1
Armstrong, D; Camacho, F; Chen, Y; Horbay, GL; Husein-Bhabha, FA; James, C; Teixeira, B	1
Esplugues, JV; Martí-Cabrera, M; Ponce, J	1
Baisley, K; Boyce, M; Delemos, B; Lee, D; Lomax, K; Morocutti, A; Warrington, S	1
Andersson, S; Nelander, H; Ohlén, K	1
Forrester, MB	1
Molnar, B; Mullner, K; Tulassay, Z	1
Boyer, K; Tolia, V	1
Andriulli, A; Annese, V; D'Ambrosio, LP; Di Mario, F; Franceschi, M; Leandro, G; Paris, F; Pilotto, A; Scarcelli, C; Seripa, D	1
Cho, YK; Choi, HS; Hwang, SJ; Jeon, WK; Kim, BI; Kim, HJ; Park, DI; Park, JS; Sohn, CI	1
Pai, N; Pai, V	1
Alonso, C; Bernal, YL; del Nozal, MJ; Jiménez, JJ; Toribio, L	1
Andersson, T; Weidolf, L	1
Charlemagne, A; Fagnani, F; Le Jeunne, P; Mouly, S	1
Gursoy, O; Memiş, D; Sut, N	1
Cho, YK; Choi, WH; Hong, CH; Hong, EJ; Jeon, WK; Kim, BI; Kim, HJ; Oh, SJ; Park, DI; Park, JH; Shon, CI; Song, MJ	1
Pellicano, R	1
Bharathi, DV; Chatki, PK; Hotha, KK; Jagadeesh, B; Mullangi, R; Naidu, A; Thriveni, K	1
Tan, VP; Wong, BC	1
Gulzar, GM; Javid, G; Khan, BA; Khan, MA; Shah, AH; Sodhi, JS; U-Saif, R; Yatoo, GN; Zargar, SA	1
Hunt, RH; Padol, S; Yaghoobi, M; Yuan, Y	1
Delemos, B; Ieni, J; Lococo, J; Miner, P; Xiang, J	1
Keyhanfar, F; Mahmoudian, M; Motevalian, M; Noubarani, M	1
El-Tantawy, AS; Khalil, SM; Mohamed, GG; Nour El-Dien, FA	1
Chang, SY; Chen, C; Chimalakonda, A; Hurley, J; Rodrigues, AD; Thorndike, D; Vuppugalla, R; Wagner, A; Yang, Z; Zvyaga, T	1
Chularojanamontri, L; Dhana, N; Jiamton, S; Jongjarearnprasert, K; Kulthanan, K; Manapajon, A; Suvanasuthi, S	1
Banahan, BF; Bentley, JP; Datar, MV; Mahabaleshwarkar, RK; Null, KD; Strum, MW; Yang, Y	1
Bhushan, R; Dixit, S; Dubey, R	1
Bruley des Varannes, S; Coudsy, B; Delemos, B; Ducrotté, P; Lococo, J; Waechter, S; Xiang, J	1
Angioli, R; Damiani, P; Improta, G; Petrella, C; Plotti, F; Scarpignato, C; Severini, C; Signore, F; Terranova, C	1
Burburan, PJ; Matubia, VN; Parkin, DW; Ramcharan, SS; Rosario, I; Shea, TA; Stockman, BJ	1
Baeg, MK; Cho, YK; Choi, KY; Choi, MG; Kim, JS; Kim, SW; Lee, IS; Lim, CH; Moon, SJ; Park, JM	1
Kim, EH; Kim, HY; Lee, SK; Park, CH; Roh, YH	1
Abad-Santos, F; Cabaleiro, T; Ochoa, D; Prieto-Pérez, R; Rivas, Â; Román, M; Sánchez-Rojas, SD; Talegón, M	1
Bilker, WB; Brensinger, CM; Flockhart, DA; Freeman, CP; Hennessy, S; Kasner, SE; Kimmel, SE; Leonard, CE	1
Akers, KS; Boyd, NK; Niece, KL	1
Accassat, S; Basset, T; Bertoletti, L; Delavenne, X; Hodin, S; Mismetti, P; Ollier, E	1
Abbas, MG; Akter, N; Akter, S; Bhuiyan, MA; Hassan, MR; Shahriar, M	1
Akyuz, F; Baran, B; Besisik, F; Demir, K; Emrence, Z; Evirgen, S; Gokturk, S; Karaca, C; Kaymakoglu, S; Ormeci, A; Soyer, OM; Ustek, D	1
Christensen, RD; Haastrup, PF; Hansen, JM; Jarbøl, DE; Paulsen, MS; Søndergaard, J	1
Ebbelaar, CF; Lammers, HA; Schobben, AF	1
Chen, MH; Chu, CJ; Hou, MC; Huang, YH; Lee, FY; Lin, HC; Lu, CL; Su, TP; Tsai, CF; Wang, YP	1
Aydın, D; Çelebi, A; Hülagü, S; Kocaman, O; Konduk, BT; Şentürk, Ö	1
Goh, KL; Zou, D	1
Li, MJ; Li, Q; Liu, LQ; Sun, M	1
Kamat, N; Kamath, A; Mallayasamy, SR; Pai, G; S, R	1
Chen, D; Fei, G; Lu, B; Wang, B; Wang, J; Wang, X; Wu, B; Zhang, L; Zou, D; Zou, X	1
Calissendorff, J; Falhammar, H; Lindh, JD; Mannheimer, B; Nathanson, D; Skov, J	1
Kan, LD; Li, LC; Wu, CY; Ying, J; Yu, ZW	1
Karimova, MM; Makarenko, OV; Masheiko, AM; Onul, NM	1
Abu-Rish, EY; Dahabiyeh, LA; Taha, MO	1
Baddam, R; Gone, V; Pasupuleti, B; Prasad, OP; Venisetty, RK	1
Abed, MN; Alassaf, FA; Alfahad, M; Jasim, MHM; Qazzaz, ME	1
Huang, X; Liu, Y; Shen, Y; Su, YW; Sun, LN; Wang, YQ; Yang, YQ; Ying, YW; Zhang, XH; Zhang, Y	1
Chen, ZN; Dai, FR; Fan, XX; Sheng, TP; Zheng, GZ	1
Arnaud, B; Arnoult, C; Escoffier, J; Hograindleur, JP; Kaba, M; Le Blévec, E; Martinez, G; Nef, S; Ray, PF; Stévant, I	1
Abad-Santos, F; Cabaleiro, T; Mejía, G; Ochoa, D; Román, M; Saiz-Rodríguez, M	1
Chen, F; Fang, B; He, X; Wang, S	1
Hancu, G; Kelemen, H; Papp, LA; Tóth, G	1
Alam, SD; Ali, I; ALOthman, ZA; Bhatt, T; Islam, MA; Jain, AK; Mohammed, AAA; Raja, R; Srisath, V	1
Chan, AT; Choi, HK; Lei, G; Lu, N; Misra, D; Neogi, T; Wei, J; Zeng, C; Zhang, Y	1
Lespessailles, E; Toumi, H	1
Lee, WP	1
Afzal, NA; Andrews, E; Beattie, RM; Hayen, A; Liddicoat, I; Tighe, MP	1

Reviews

30 review(s) available for pantoprazole and rabeprazole

Article	Year
Recent advances in proton pump inhibitors and management of acid-peptic disorders. Bioorganic & medicinal chemistry, 2007, Feb-01, Volume: 15, Issue:3 Topics: Animals; Anti-Ulcer Agents; Gastric Acid; Gastroesophageal Reflux; Helicobacter Infections; Humans; Peptic Ulcer; Proton Pump Inhibitors	2007
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Recent developments in anti-Trichomonas research: An update review. European journal of medicinal chemistry, 2018, Jan-01, Volume: 143 Topics: Antiparasitic Agents; Biological Products; Dose-Response Relationship, Drug; Humans; Molecular Structure; Parasitic Sensitivity Tests; Structure-Activity Relationship; Trichomonas; Trichomonas Infections	2018
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators. European journal of medicinal chemistry, 2022, Jul-05, Volume: 237 Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplastic Stem Cells	2022
Are the orally administered proton pump inhibitors equivalent? A comparison of lansoprazole, omeprazole, pantoprazole, and rabeprazole. Current gastroenterology reports, 2000, Volume: 2, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Drug Interactions; Duodenal Ulcer; Gastroesophageal Reflux; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Sulfoxides	2000
[H2 receptor antagonists and proton pump inhibitors: principles and rules of use]. La Revue du praticien, 2001, Apr-15, Volume: 51, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Age Factors; Aged; Anti-Ulcer Agents; Benzimidazoles; Child; Child, Preschool; Duodenal Ulcer; Enzyme Inhibitors; Esophagitis, Peptic; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Infant; Infant, Newborn; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Ranitidine; Stomach Ulcer; Sulfoxides	2001
Proton pump inhibitors and their drug interactions: an evidence-based approach. European journal of gastroenterology & hepatology, 2001, Volume: 13, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Enzyme Inhibitors; Gastrointestinal Agents; Humans; Lansoprazole; Mixed Function Oxygenases; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Sulfoxides	2001
Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials. Clinical therapeutics, 2001, Volume: 23, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Gastroesophageal Reflux; Humans; Lansoprazole; Omeprazole; Pantoprazole; Rabeprazole; Randomized Controlled Trials as Topic; Ranitidine; Sulfoxides; Treatment Outcome	2001
[Comparative study of proton pump inhibitors]. Orvosi hetilap, 2001, Sep-09, Volume: 142, Issue:36 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Duodenal Ulcer; Enzyme Inhibitors; Gastric Acid; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Proton-Translocating ATPases; Rabeprazole; Stomach Ulcer; Sulfoxides	2001
Review article: rabeprazole-based therapy in Helicobacter pylori eradication. Alimentary pharmacology & therapeutics, 2002, Volume: 16 Suppl 1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Clinical Trials as Topic; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole; Sulfoxides	2002
Single vs. double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta-analysis. Alimentary pharmacology & therapeutics, 2002, Volume: 16, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Pantoprazole; Penicillins; Proton Pump Inhibitors; Rabeprazole; Sulfoxides; Treatment Outcome	2002
The pharmacology and clinical relevance of proton pump inhibitors. Current gastroenterology reports, 2002, Volume: 4, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Gastric Acid; Gastroesophageal Reflux; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Sulfoxides; Treatment Outcome	2002
[All proton pump inhibitors are equally efficacious in standard dosages]. Lakartidningen, 2003, Jun-19, Volume: 100, Issue:25 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Dose-Response Relationship, Drug; Enzyme Inhibitors; Esomeprazole; Gastric Acid; Gastroesophageal Reflux; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Sulfoxides	2003
[Use of proton pump inhibitors in the treatment of gastroesophageal reflux disease]. Klinicheskaia meditsina, 2003, Volume: 81, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Enzyme Inhibitors; Gastroesophageal Reflux; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Sulfoxides; Treatment Outcome	2003
Effectiveness of proton pump inhibitors: beyond cost. Reviews in gastroenterological disorders, 2004, Volume: 4 Suppl 4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Enzyme Inhibitors; Esophagitis; Gastroesophageal Reflux; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Sulfoxides; Treatment Outcome	2004
What is potent acid inhibition, and how can it be achieved? Drugs, 2005, Volume: 65 Suppl 1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Clinical Trials as Topic; Esomeprazole; Gastric Acid; Humans; Lansoprazole; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole; Sulfoxides	2005
Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors? European journal of clinical pharmacology, 2006, Volume: 62, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adverse Drug Reaction Reporting Systems; Enzyme Inhibitors; Esomeprazole; Humans; Lansoprazole; Muscular Diseases; Myositis; Omeprazole; Pantoprazole; Polymyositis; Proton Pump Inhibitors; Rabeprazole; Rhabdomyolysis	2006
Systematic review: proton pump inhibitors (PPIs) for the healing of reflux oesophagitis - a comparison of esomeprazole with other PPIs. Alimentary pharmacology & therapeutics, 2006, Sep-01, Volume: 24, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Clinical Trials as Topic; Enzyme Inhibitors; Esomeprazole; Esophagitis, Peptic; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Treatment Outcome	2006
[Safety of proton pump inhibitors]. Medicina clinica, 2006, Nov-25, Volume: 127, Issue:20 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Adult; Age Factors; Aged; Animals; Anti-Ulcer Agents; Cimetidine; Enzyme Inhibitors; Famotidine; Female; Fetus; Histamine H2 Antagonists; Humans; Lactation; Lansoprazole; Meta-Analysis as Topic; Nizatidine; Omeprazole; Pantoprazole; Pregnancy; Proton Pump Inhibitors; Proton-Translocating ATPases; Rabeprazole; Ranitidine; Safety; Time Factors	2006
[Clinical pharmacological aspects of the proton pump inhibitor therapy: importance of pharmacogenetic differences in the clinical practice]. Orvosi hetilap, 2007, Mar-25, Volume: 148, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Drug Interactions; Enzyme Inhibitors; Esomeprazole; Humans; Lansoprazole; Liver; Omeprazole; Pantoprazole; Polymorphism, Genetic; Proton Pump Inhibitors; Rabeprazole	2007
Recent advances in chirally pure proton pump inhibitors. Journal of the Indian Medical Association, 2007, Volume: 105, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Esomeprazole; Gastroesophageal Reflux; Humans; Isomerism; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole	2007
Stereoselective disposition of proton pump inhibitors. Clinical drug investigation, 2008, Volume: 28, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Esomeprazole; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Stereoisomerism	2008
[Proton pump inhibitors, a family of drugs in continuous expansion]. Minerva gastroenterologica e dietologica, 2000, Volume: 46, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Inflammatory Agents, Non-Steroidal; Barrett Esophagus; Duodenal Ulcer; Dyspepsia; Gastric Acid; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Rats; Stomach Ulcer	2000
Impact of oesophagitis classification in evaluating healing of erosive oesophagitis after therapy with proton pump inhibitors: a pooled analysis. European journal of gastroenterology & hepatology, 2010, Volume: 22, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Databases, Factual; Endoscopy, Gastrointestinal; Esomeprazole; Esophagitis; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Randomized Controlled Trials as Topic; Registries; Wound Healing	2010
The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis. PloS one, 2014, Volume: 9, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Dexlansoprazole; Esomeprazole; Humans; Lansoprazole; Magnesium; Odds Ratio; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Risk Factors; Treatment Outcome	2014
East Asian perspective on the interaction between proton pump inhibitors and clopidogrel. Journal of gastroenterology and hepatology, 2017, Volume: 32, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anticoagulants; Asia, Eastern; Asian People; Aspirin; Clopidogrel; Cytochrome P-450 CYP2C19; Dexlansoprazole; Drug Interactions; Drug Therapy, Combination; Gastroesophageal Reflux; Gastrointestinal Hemorrhage; Humans; Isoenzymes; Pantoprazole; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Proton Pump Inhibitors; Rabeprazole; Ticlopidine	2017
Comparative effectiveness and acceptability of the FDA-licensed proton pump inhibitors for erosive esophagitis: A PRISMA-compliant network meta-analysis. Medicine, 2017, Volume: 96, Issue:39 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Comparative Effectiveness Research; Dexlansoprazole; Esomeprazole; Esophagitis, Peptic; Female; Heartburn; Humans; Lansoprazole; Male; Middle Aged; Network Meta-Analysis; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Treatment Outcome; United States; United States Food and Drug Administration	2017
Chiral separation in the class of proton pump inhibitors by chromatographic and electromigration techniques: An overview. Electrophoresis, 2021, Volume: 42, Issue:17-18 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Electrophoresis; Esomeprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole	2021
Proton Pump Inhibitors and Bone Health: An Update Narrative Review. International journal of molecular sciences, 2022, 09-14, Volume: 23, Issue:18 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Antacids; Bone Density; Dexlansoprazole; Esomeprazole; Humans; Lansoprazole; Omeprazole; Osteoporotic Fractures; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; United States	2022
Pharmacological treatment of gastro-oesophageal reflux in children. The Cochrane database of systematic reviews, 2023, 08-22, Volume: 8 Topics: Adolescent; Child; Esomeprazole; Gastroesophageal Reflux; Humans; Infant; Infant, Newborn; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Ranitidine	2023

Trials

19 trial(s) available for pantoprazole and rabeprazole

Article	Year
Acid inhibition on the first day of dosing: comparison of four proton pump inhibitors. Alimentary pharmacology & therapeutics, 2003, Jun-15, Volume: 17, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Antacids; Benzimidazoles; Cross-Over Studies; Double-Blind Method; Female; Gastric Acid; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Sulfoxides; Time Factors	2003
Effect of a single oral dose of rabeprazole on nocturnal acid breakthrough and nocturnal alkaline amplitude. World journal of gastroenterology, 2003, Volume: 9, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Alkalies; Anti-Ulcer Agents; Benzimidazoles; Circadian Rhythm; Female; Gastric Acid; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Rabeprazole; Sulfoxides	2003
Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study. The American journal of gastroenterology, 2003, Volume: 98, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Anti-Ulcer Agents; Benzimidazoles; Chi-Square Distribution; Cross-Over Studies; Esomeprazole; Female; Gastric Acid; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Lansoprazole; Least-Squares Analysis; Male; Middle Aged; Omeprazole; Pantoprazole; Rabeprazole; Sulfoxides; Treatment Outcome	2003
Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms. European journal of clinical pharmacology, 2004, Volume: 60, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Anti-Ulcer Agents; Benzimidazoles; Cross-Over Studies; Esomeprazole; Female; Gastric Acid; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Rabeprazole; Sulfoxides; Treatment Outcome	2004
Oral rabeprazole vs. intravenous pantoprazole: a comparison of the effect on intragastric pH in healthy subjects. Alimentary pharmacology & therapeutics, 2007, Jan-15, Volume: 25, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Antacids; Anti-Ulcer Agents; Cross-Over Studies; Double-Blind Method; Female; Gastric Acid; Humans; Hydrogen-Ion Concentration; Infusions, Intravenous; Male; Pantoprazole; Rabeprazole	2007
Pharmacodynamic effects of single doses of rabeprazole 20 mg and pantoprazole 40 mg in patients with GERD and nocturnal heartburn. Alimentary pharmacology & therapeutics, 2007, Feb-15, Volume: 25, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Ulcer Agents; Cross-Over Studies; Female; Gastric Acid; Gastric Acidity Determination; Gastroesophageal Reflux; Heartburn; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Pantoprazole; Rabeprazole	2007
Comparison of four proton pump inhibitors for the short-term treatment of esophagitis in elderly patients. World journal of gastroenterology, 2007, Sep-07, Volume: 13, Issue:33 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Anti-Ulcer Agents; Endoscopy, Gastrointestinal; Esophagitis; Female; Humans; Lansoprazole; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Treatment Outcome	2007
Double-dose, new-generation proton pump inhibitors do not improve Helicobacter pylori eradication rate. Helicobacter, 2007, Volume: 12, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole	2007
Effect of proton pump inhibitors on gastric juice volume, gastric pH and gastric intramucosal pH in critically ill patients : a randomized, double-blind, placebo-controlled study. Clinical drug investigation, 2008, Volume: 28, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Critical Illness; Double-Blind Method; Esomeprazole; Female; Gastric Acidity Determination; Gastric Juice; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Rabeprazole	2008
Comparison of p.o. or i.v. proton pump inhibitors on 72-h intragastric pH in bleeding peptic ulcer. Journal of gastroenterology and hepatology, 2009, Volume: 24, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adolescent; Adult; Drug Administration Schedule; Duodenal Ulcer; Duodenoscopy; Female; Gastric Acidity Determination; Gastroscopy; Hemostatic Techniques; Humans; Hydrogen-Ion Concentration; Infusions, Intravenous; Male; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer Hemorrhage; Proton Pump Inhibitors; Rabeprazole; Recurrence; Stomach Ulcer; Time Factors; Treatment Outcome; Young Adult	2009
Effects of a single dose of rabeprazole 20 mg and pantoprazole 40 mg on 24-h intragastric acidity and oesophageal acid exposure: a randomized study in gastro-oesophageal reflux disease patients with a history of nocturnal heartburn. Alimentary pharmacology & therapeutics, 2010, Volume: 31, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Ulcer Agents; Cross-Over Studies; Female; Gastric Acid; Gastroesophageal Reflux; Heartburn; Humans; Male; Middle Aged; Pantoprazole; Rabeprazole; Single-Blind Method; Treatment Outcome; Young Adult	2010
Improved HPLC method for determination of four PPIs, omeprazole, pantoprazole, lansoprazole and rabeprazole in human plasma. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 2010, Volume: 13, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Chromatography, High Pressure Liquid; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Reproducibility of Results; Young Adult	2010
On-demand proton pump inhibitory treatment in overweight/obese patients with gastroesophageal reflux disease: are there pharmacodynamic arguments for using higher doses? Digestion, 2013, Volume: 88, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Cross-Over Studies; Double-Blind Method; Female; Gastroesophageal Reflux; Humans; Male; Middle Aged; Obesity; Overweight; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Young Adult	2013
Preprocedural rabeprazole treatment before endoscopic submucosal dissection for gastric neoplasms. Digestive diseases and sciences, 2014, Volume: 59, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Dissection; Female; Gastric Mucosa; Gastrointestinal Hemorrhage; Gastroscopy; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Monitoring, Physiologic; Pantoprazole; Postoperative Hemorrhage; Preoperative Care; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Second-Look Surgery; Stomach; Stomach Neoplasms; Wound Healing	2014
In vitro and in vivo evaluation of drug-drug interaction between dabigatran and proton pump inhibitors. Fundamental & clinical pharmacology, 2015, Volume: 29, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Cell Line, Tumor; Cyclosporine; Dabigatran; Drug Interactions; Humans; Lansoprazole; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Thrombin; Young Adult	2015
Cognitive impact after short-term exposure to different proton pump inhibitors: assessment using CANTAB software. Alzheimer's research & therapy, 2015, Dec-27, Volume: 7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Cognition; Esomeprazole; Female; Humans; Lansoprazole; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Software; Young Adult	2015
Comparison of the effects of esomeprazole 40 mg, rabeprazole 20 mg, lansoprazole 30 mg, and pantoprazole 40 mg on intragastrıc pH in extensive metabolizer patients with gastroesophageal reflux disease. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2016, Volume: 27, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Cross-Over Studies; Cytochrome P-450 CYP2C19; Double-Blind Method; Esomeprazole; Female; Gastric Acid; Gastroesophageal Reflux; Genotype; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Middle Aged; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Treatment Outcome	2016
Clinical Impact of Co-medication of Levetiracetam and Clobazam with Proton Pump Inhibitors: A Drug Interaction Study. Current drug metabolism, 2020, Volume: 21, Issue:2 Topics: Anticonvulsants; Clobazam; Drug Interactions; Esomeprazole; Female; Humans; Levetiracetam; Male; Pantoprazole; Proton Pump Inhibitors; Rabeprazole	2020
Effect of food on the pharmacokinetics of omeprazole, pantoprazole and rabeprazole. BMC pharmacology & toxicology, 2020, 07-25, Volume: 21, Issue:1 Topics: Adult; Anti-Ulcer Agents; Cross-Over Studies; Cytochrome P-450 CYP2C19; Dietary Fats; Fasting; Female; Food-Drug Interactions; Genotype; Humans; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Young Adult	2020

Other Studies

59 other study(ies) available for pantoprazole and rabeprazole

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6 Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics	2010
Antiprotozoal activity of proton-pump inhibitors. Bioorganic & medicinal chemistry letters, 2011, Dec-15, Volume: 21, Issue:24 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antiprotozoal Agents; Drug Design; Entamoeba histolytica; Giardia lamblia; Humans; Lansoprazole; Omeprazole; Pantoprazole; Parasitic Diseases; Proton Pump Inhibitors; Rabeprazole; Trichomonas vaginalis	2011
Repositioning proton pump inhibitors as anticancer drugs by targeting the thioesterase domain of human fatty acid synthase. Journal of medicinal chemistry, 2015, Jan-22, Volume: 58, Issue:2 Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Drug Repositioning; Fatty Acid Synthases; Humans; Hydrogen-Ion Concentration; Lansoprazole; Palmitic Acid; Palmitoyl-CoA Hydrolase; Protein Structure, Tertiary; Proton Pump Inhibitors	2015
Identification of ebselen as a potent inhibitor of insulin degrading enzyme by a drug repurposing screening. European journal of medicinal chemistry, 2019, Oct-01, Volume: 179 Topics: Azoles; Biocatalysis; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Repositioning; Enzyme Inhibitors; High-Throughput Screening Assays; Humans; Insulysin; Isoindoles; Molecular Structure; Organoselenium Compounds; Structure-Activity Relationship	2019
Effects of benzimidazole derivatives on cytochrome P450 1A1 expression in a human hepatoma cell line. Xenobiotica; the fate of foreign compounds in biological systems, 1997, Volume: 27, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; beta-Naphthoflavone; Cell Line; Cytochrome P-450 CYP1A1; Enzyme Activation; Humans; Lansoprazole; Omeprazole; Pantoprazole; Rabeprazole; RNA, Messenger; Sulfoxides	1997
Sites of reaction of the gastric H,K-ATPase with extracytoplasmic thiol reagents. The Journal of biological chemistry, 1997, Sep-05, Volume: 272, Issue:36 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amino Acid Sequence; Animals; Anti-Ulcer Agents; Benzimidazoles; Enzyme Inhibitors; Gastric Acid; H(+)-K(+)-Exchanging ATPase; Indicators and Reagents; Lansoprazole; Molecular Sequence Data; Omeprazole; Oxidoreductases; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Sequence Homology, Amino Acid; Sphingosine; Stomach; Sulfhydryl Compounds; Sulfoxides; Swine	1997
Selective inhibition of the gastric H+,K(+)-ATPase by omeprazole and related compounds. Annals of the New York Academy of Sciences, 1997, Nov-03, Volume: 834 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Benzimidazoles; Binding Sites; Enzyme Inhibitors; Gastric Mucosa; H(+)-K(+)-Exchanging ATPase; Humans; Kinetics; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Structure-Activity Relationship; Sulfoxides; Valinomycin	1997
Treatment strategies for gastroesophageal reflux disease. Clinical therapeutics, 2000, Volume: 22, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Cytochrome P-450 Enzyme System; Drug Interactions; Gastroesophageal Reflux; Humans; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Sulfoxides	2000
Relative efficacies of gastric proton-pump inhibitors on a milligram basis: desired and undesired SH reactions. Impact of chirality. Scandinavian journal of gastroenterology. Supplement, 2001, Issue:234 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Enzyme Inhibitors; Esomeprazole; Half-Life; Humans; Hydrogen-Ion Concentration; Lansoprazole; Omeprazole; Pantoprazole; Parietal Cells, Gastric; Prodrugs; Proton Pump Inhibitors; Rabeprazole; Sulfoxides	2001
Proton pump inhibitors: an update. American family physician, 2002, Jul-15, Volume: 66, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Drug Interactions; Esomeprazole; Gastroesophageal Reflux; Humans; Lansoprazole; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole; Sulfoxides	2002
Differential drug-induced mRNA expression of human CYP3A4 compared to CYP3A5, CYP3A7 and CYP3A43. European journal of pharmacology, 2003, Apr-11, Volume: 466, Issue:1-2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Cell Line, Tumor; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Gene Expression Regulation; Humans; Hypericum; Lansoprazole; Omeprazole; Pantoprazole; Plant Preparations; Rabeprazole; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfoxides	2003
Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities. Drug metabolism and disposition: the biological fate of chemicals, 2004, Volume: 32, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Esomeprazole; Humans; Lansoprazole; Liver; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Proton Pumps; Rabeprazole; Sulfoxides	2004
Chiral separation of omeprazole and several related benzimidazoles using supercritical fluid chromatography. Journal of separation science, 2004, Volume: 27, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Alcohols; Amylose; Benzimidazoles; Chromatography; Lansoprazole; Models, Chemical; Omeprazole; Pantoprazole; Pressure; Rabeprazole; Stereoisomerism; Sulfoxides; Temperature; Time Factors	2004
[Choice of proton pump inhibitors--does it play any role?]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2004, Oct-21, Volume: 124, Issue:20 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Dose-Response Relationship, Drug; Drugs, Generic; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Sulfoxides	2004
Results of triple eradication therapy in Japanese children: a retrospective multicenter study. Journal of gastroenterology, 2004, Volume: 39, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Child; Child, Preschool; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Humans; Infant; Lansoprazole; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Sulfoxides	2004
Spillover effects of restrictive drug formularies: a case study of PacifiCare in California. The American journal of managed care, 2005, Volume: 11, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; California; Formularies as Topic; Gatekeeping; Managed Care Programs; Omeprazole; Organizational Case Studies; Pantoprazole; Physician-Patient Relations; Rabeprazole; Sulfoxides	2005
Cost effective prescribing of proton pump inhibitors (PPI's) in the GMS Scheme. Irish medical journal, 2005, Volume: 98, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Community Pharmacy Services; Cost-Benefit Analysis; Drug Costs; Enzyme Inhibitors; Health Care Surveys; Humans; Ireland; Lansoprazole; National Health Programs; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Sulfoxides	2005
Cost-effectiveness comparison of current proton-pump inhibitors to treat gastro-oesophageal reflux disease in the UK. Current medical research and opinion, 2005, Volume: 21, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Esomeprazole; Gastroesophageal Reflux; Humans; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Sulfoxides; United Kingdom	2005
A therapeutic substitution policy for proton pump inhibitors: clinical and economic consequences. Clinical pharmacology and therapeutics, 2006, Volume: 79, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimidazoles; British Columbia; Cost Savings; Databases, Factual; Drug Utilization Review; Female; Health Services for the Aged; Hospitalization; Humans; Insurance, Pharmaceutical Services; Lansoprazole; Male; Omeprazole; Pantoprazole; Practice Patterns, Physicians'; Rabeprazole; Sulfoxides	2006
Sub-optimal proton pump inhibitor dosing is prevalent in patients with poorly controlled gastro-oesophageal reflux disease. Alimentary pharmacology & therapeutics, 2006, May-15, Volume: 23, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Drug Administration Schedule; Enzyme Inhibitors; Female; Gastroesophageal Reflux; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Sulfoxides; Time Factors	2006
Preparative chiral chromatography and chiroptical characterization of enantiomers of omeprazole and related benzimidazoles. Chirality, 2007, Volume: 19, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Chromatography; Chromatography, Supercritical Fluid; Circular Dichroism; Enzyme Inhibitors; Lansoprazole; Models, Chemical; Molecular Conformation; Molecular Structure; Omeprazole; Pantoprazole; Rabeprazole; Stereoisomerism	2007
Pattern of proton pump inhibitor calls to Texas poison centers, 1998-2004. Journal of toxicology and environmental health. Part A, 2007, Apr-15, Volume: 70, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Animals; Child; Child, Preschool; Enzyme Inhibitors; Female; Humans; Lansoprazole; Male; Omeprazole; Pantoprazole; Poison Control Centers; Poisoning; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Texas	2007
Long-term proton pump inhibitor use in children: a retrospective review of safety. Digestive diseases and sciences, 2008, Volume: 53, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Child; Child, Preschool; Esophagitis; Female; Gastrins; Humans; Lansoprazole; Liver Function Tests; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Vitamin B 12	2008
Semipreparative chiral supercritical fluid chromatography in the fractionation of lansoprazole and two related antiulcer drugs enantiomers. Journal of separation science, 2008, Volume: 31, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Chemical Fractionation; Chemistry Techniques, Analytical; Chemistry, Pharmaceutical; Chromatography; Chromatography, Supercritical Fluid; Equipment Design; Lansoprazole; Models, Chemical; Pantoprazole; Pharmaceutical Preparations; Rabeprazole; Stereoisomerism; Time Factors	2008
[General practitioners' management of gastroesophageal reflux in France in 2005: a pharmacoeconomic study]. Presse medicale (Paris, France : 1983), 2008, Volume: 37, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Costs and Cost Analysis; Esomeprazole; Family Practice; Female; France; Gastroesophageal Reflux; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pumps; Rabeprazole	2008
[Comparison of Helicobacter pylori eradication rate in patients with non-ulcer dyspepsia and peptic ulcer diseases according to proton pump inhibitors]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2008, Volume: 52, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Data Interpretation, Statistical; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole	2008
Simultaneous estimation of four proton pump inhibitors--lansoprazole, omeprazole, pantoprazole and rabeprazole: development of a novel generic HPLC-UV method and its application to clinical pharmacokinetic study. Biomedical chromatography : BMC, 2009, Volume: 23, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Chromatography, High Pressure Liquid; Drug Stability; Humans; Isoxazoles; Lansoprazole; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Zonisamide	2009
Management of acute peptic ulcers: how ethnicity, different proton pump inhibitors and mechanism of delivery alter the equation. Journal of gastroenterology and hepatology, 2009, Volume: 24, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Asian People; Drug Administration Schedule; Duodenal Ulcer; Duodenoscopy; Gastroscopy; Hemostatic Techniques; Humans; Hydrogen-Ion Concentration; Infusions, Intravenous; Omeprazole; Pantoprazole; Peptic Ulcer Hemorrhage; Proton Pump Inhibitors; Rabeprazole; Recurrence; Stomach Ulcer; Time Factors; Treatment Outcome	2009
Spectrophotometric determination of peptic ulcer sulfur-containing drugs in bulk form and in tablets. Drug testing and analysis, 2010, Volume: 2, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Iodates; Limit of Detection; Omeprazole; Pantoprazole; Potassium Compounds; Powders; Proton Pump Inhibitors; Rabeprazole; Spectrophotometry; Sulfur Compounds; Tablets	2010
Evaluation of six proton pump inhibitors as inhibitors of various human cytochromes P450: focus on cytochrome P450 2C19. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aryl Hydrocarbon Hydroxylases; Biotransformation; Cells, Cultured; Computer Simulation; Cytochrome P-450 CYP2C19; Dealkylation; Dexlansoprazole; Diazepam; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Esomeprazole; Hepatocytes; Humans; Kinetics; Lansoprazole; Liver; Microsomes, Liver; Models, Biological; NADP; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Recombinant Proteins; Substrate Specificity	2012
Cutaneous reactions to proton pump inhibitors: a case-control study. Journal of drugs in dermatology : JDD, 2012, Volume: 11, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Angioedema; Case-Control Studies; Chi-Square Distribution; Drug Eruptions; Esomeprazole; Exanthema; Female; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Prevalence; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Statistics, Nonparametric; Stevens-Johnson Syndrome; Thailand; Urticaria; Young Adult	2012
Risk of adverse cardiovascular outcomes and all-cause mortality associated with concomitant use of clopidogrel and proton pump inhibitors in elderly patients. Current medical research and opinion, 2013, Volume: 29, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Case-Control Studies; Clopidogrel; Cohort Studies; Coronary Artery Bypass; Drug Interactions; Drug Therapy, Combination; Esomeprazole; Female; Humans; Lansoprazole; Male; Myocardial Infarction; Omeprazole; Pantoprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Rabeprazole; Risk; Stroke; Ticlopidine	2013
Normal and polar-organic-phase high-performance liquid chromatographic enantioresolution of omeprazole, rabeprazole, lansoprazole and pantoprazole using monochloro-methylated cellulose-based chiral stationary phase and determination of dexrabeprazole. Biomedical chromatography : BMC, 2014, Volume: 28, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Chromatography, High Pressure Liquid; Lansoprazole; Omeprazole; Pantoprazole; Rabeprazole; Stereoisomerism	2014
Relaxant effect of proton pump inhibitors on in vitro myometrium from pregnant women. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2014, Feb-14, Volume: 52 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Apamin; Calcium; Dinoprostone; Esomeprazole; Female; Humans; In Vitro Techniques; Indomethacin; Lansoprazole; Muscle Contraction; Myometrium; NG-Nitroarginine Methyl Ester; Omeprazole; Oxytocin; Pantoprazole; Peptides; Potassium Chloride; Pregnancy; Proton Pump Inhibitors; Rabeprazole; Tocolytic Agents	2014
Identification of proton-pump inhibitor drugs that inhibit Trichomonas vaginalis uridine nucleoside ribohydrolase. Bioorganic & medicinal chemistry letters, 2014, Feb-15, Volume: 24, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Dose-Response Relationship, Drug; Molecular Structure; N-Glycosyl Hydrolases; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Structure-Activity Relationship; Trichomonas vaginalis	2014
Evaluation of the relationship between polymorphisms in CYP2C19 and the pharmacokinetics of omeprazole, pantoprazole and rabeprazole. Pharmacogenomics, 2014, Volume: 15, Issue:15 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Cytochrome P-450 CYP2C19; Female; Genetic Association Studies; Genotype; Humans; Inactivation, Metabolic; Male; Omeprazole; Pantoprazole; Polymorphism, Genetic; Rabeprazole	2014
Comparative risk of ischemic stroke among users of clopidogrel together with individual proton pump inhibitors. Stroke, 2015, Volume: 46, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Brain Ischemia; Clopidogrel; Data Interpretation, Statistical; Drug Therapy, Combination; Esomeprazole; Female; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Proportional Hazards Models; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Risk; Stroke; Ticlopidine	2015
In vitro study of the variable effects of proton pump inhibitors on voriconazole. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antifungal Agents; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Drug Interactions; Esomeprazole; Humans; Lansoprazole; Microsomes, Liver; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Voriconazole	2015
Effect of cytochrome P450 2C19 polymorphisms on the Helicobacter pylori eradication rate following two-week triple therapy with pantoprazole or rabeprazole. European review for medical and pharmacological sciences, 2016, Volume: 20, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Polymorphism, Restriction Fragment Length; Proton Pump Inhibitors; Rabeprazole; Young Adult	2016
Medical and non-medical predictors of initiating long-term use of proton pump inhibitors: a nationwide cohort study of first-time users during a 10-year period. Alimentary pharmacology & therapeutics, 2016, Volume: 44, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Cohort Studies; Esomeprazole; Female; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Young Adult	2016
[Switching to a generic drugA blessing or a curse?]. Nederlands tijdschrift voor geneeskunde, 2016, Volume: 160 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Drugs, Generic; Esomeprazole; Humans; Pantoprazole; Rabeprazole; Treatment Outcome; Zollinger-Ellison Syndrome	2016
Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in A Population Study. Gastroenterology, 2017, Volume: 152, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administrative Claims, Healthcare; Adult; Aged; Case-Control Studies; Esomeprazole; Female; Hepatic Encephalopathy; Humans; Incidence; Insurance, Health; Lansoprazole; Liver Cirrhosis; Longitudinal Studies; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Taiwan	2017
Direct costs for nonsurgical management of Chronic Pancreatitis in a tertiary care teaching hospital. Expert review of pharmacoeconomics & outcomes research, 2018, Volume: 18, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Aged; Ambulatory Care; Child; Cost-Benefit Analysis; Cross-Sectional Studies; Enzyme Replacement Therapy; Female; Health Care Costs; Hospitalization; Hospitals, Teaching; Humans; India; Male; Middle Aged; Pancreatitis, Chronic; Pantoprazole; Rabeprazole; Retrospective Studies; Tertiary Healthcare; Young Adult	2018
Empirical treatment of outpatients with gastroesophageal reflux disease with proton pump inhibitors: A survey of Chinese patients (the ENLIGHT Study). Journal of gastroenterology and hepatology, 2018, Volume: 33, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Asian People; Esomeprazole; Female; Gastroesophageal Reflux; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Outpatients; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Time Factors; Treatment Outcome; Young Adult	2018
Associations of proton pump inhibitors and hospitalization due to hyponatremia: A population-based case-control study. European journal of internal medicine, 2019, Volume: 59 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Esomeprazole; Female; Hospitalization; Humans; Hyponatremia; Lansoprazole; Logistic Models; Male; Middle Aged; Multivariate Analysis; Omeprazole; Pantoprazole; Population; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Sweden; Young Adult	2019
The status of proton pump inhibitor use: a prescription survey of 45 hospitals in China. Revista espanola de enfermedades digestivas, 2019, Volume: 111, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; China; Comorbidity; Esomeprazole; Female; Health Care Surveys; Hospitals; Humans; Inappropriate Prescribing; Lansoprazole; Male; Middle Aged; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Young Adult	2019
Qualimetric analysis of proton pump inhibitors in Ukraine. Wiadomosci lekarskie (Warsaw, Poland : 1960), 2019, Volume: 72, Issue:9 cz 2 Topics: Dexlansoprazole; Esomeprazole; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Quality Control; Rabeprazole; Ukraine	2019
Inhibition of monoglyceride lipase by proton pump inhibitors: investigation using docking and in vitro experiments. Pharmacological reports : PR, 2020, Volume: 72, Issue:2 Topics: Humans; Lansoprazole; Molecular Docking Simulation; Molecular Structure; Monoacylglycerol Lipases; Pantoprazole; Protein Binding; Proton Pump Inhibitors; Rabeprazole; Substrate Specificity	2020
Comparison of Antioxidant Effects of the Proton Pump-Inhibiting Drugs Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, and Rabeprazole. Pharmacology, 2020, Volume: 105, Issue:11-12 Topics: Antioxidants; Ascorbic Acid; Biphenyl Compounds; Esomeprazole; Free Radicals; In Vitro Techniques; Inhibitory Concentration 50; Lansoprazole; Omeprazole; Pantoprazole; Picrates; Proton Pump Inhibitors; Rabeprazole; Spectrophotometry	2020
Simultaneous enantioselective determination of omeprazole, rabeprazole, lansoprazole, and pantoprazole enantiomers in human plasma by chiral liquid chromatography-tandem mass spectrometry. Journal of separation science, 2020, Volume: 43, Issue:16 Topics: Chromatography, High Pressure Liquid; Humans; Lansoprazole; Molecular Structure; Omeprazole; Pantoprazole; Rabeprazole; Stereoisomerism; Tandem Mass Spectrometry	2020
Cooperative Binding and Stepwise Encapsulation of Drug Molecules by Sulfonylcalixarene-Based Metal-Organic Supercontainers. Molecules (Basel, Switzerland), 2020, Jun-08, Volume: 25, Issue:11 Topics: Binding Sites; Calixarenes; Metal-Organic Frameworks; Metals; Models, Molecular; Molecular Structure; Pantoprazole; Rabeprazole; Sulfinic Acids	2020
Pantoprazole, a proton-pump inhibitor, impairs human sperm motility and capacitation in vitro. Andrology, 2020, Volume: 8, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Fertilization; Humans; Lansoprazole; Male; Membrane Potentials; Middle Aged; Omeprazole; Pantoprazole; Phosphorylation; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Semen Analysis; Sperm Capacitation; Sperm Maturation; Sperm Motility; Spermatozoa; Young Adult	2020
Simultaneous Quantitative Analysis of Six Proton-Pump Inhibitors with a Single Marker and Evaluation of Stability of Investigated Drugs in Polypropylene Syringes for Continuous Infusion Use. Drug design, development and therapy, 2020, Volume: 14 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Chromatography, High Pressure Liquid; Drugs, Investigational; Esomeprazole; Humans; Lansoprazole; Molecular Structure; Omeprazole; Pantoprazole; Polypropylenes; Proton Pump Inhibitors; Rabeprazole	2020
A comparative study of chiral separation of proton pump inhibitors by supercritical fluid chromatography and high-performance liquid chromatography. Journal of separation science, 2022, Volume: 45, Issue:4 Topics: Chromatography, High Pressure Liquid; Chromatography, Supercritical Fluid; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Stereoisomerism	2022
Proton pump inhibitor therapy and risk of knee replacement surgery: a general population-based cohort study. Osteoarthritis and cartilage, 2022, Volume: 30, Issue:4 Topics: Cohort Studies; Esomeprazole; Humans; Lansoprazole; Omeprazole; Osteoarthritis, Knee; Pantoprazole; Proton Pump Inhibitors; Rabeprazole	2022
Suppression of vacuolar-type ATPase and induction of endoplasmic reticulum stress by proton pump inhibitors. Journal of the Chinese Medical Association : JCMA, 2022, 09-01, Volume: 85, Issue:9 Topics: Activating Transcription Factor 6; Dexlansoprazole; Endoplasmic Reticulum Stress; Esomeprazole; Humans; Pantoprazole; Protein Serine-Threonine Kinases; Proton Pump Inhibitors; Rabeprazole; Reactive Oxygen Species; Stomach Neoplasms; Superoxide Dismutase; Vacuolar Proton-Translocating ATPases	2022